tiprankstipranks
Trending News
More News >
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
US Market

Verona Pharma (VRNA) Technical Analysis

Compare
786 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Verona Pharma Plc’s (VRNA) Moving Averages Convergence Divergence (MACD) indicator is 4.72, suggesting Verona Pharma Plc is a Sell.
Verona Pharma Plc’s (VRNA) 20-Day exponential moving average is 76.39, while Verona Pharma Plc’s (VRNA) share price is $85.54, making it a Buy.
Verona Pharma Plc’s (VRNA) 50-Day exponential moving average is 70.16, while Verona Pharma Plc’s (VRNA) share price is $85.54, making it a Buy.

Verona Pharma (VRNA) Pivot Points

Jun 07, 2025, 07:50 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
79.92
81.78
82.88
84.73
85.84
87.69
88.79
Fibonacci
81.78
82.91
83.61
84.73
85.86
86.56
87.69
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verona Pharma (VRNA) Moving Averages

Jun 07, 2025, 07:50 AM
Period
Simple
Exponential
MA5
83.93Buy
83.30Buy
MA10
79.44Buy
80.38Buy
MA20
74.43Buy
76.39Buy
MA50
67.44Buy
70.16Buy
MA100
64.25Buy
63.28Buy
MA200
49.77Buy
49.84Buy
Verona Pharma Plc’s (VRNA) 10-Day exponential moving average is 80.38, while Verona Pharma Plc’s (VRNA) share price is $85.54, making it a Buy.
Verona Pharma Plc’s (VRNA) 100-Day exponential moving average is 63.28, while Verona Pharma Plc’s (VRNA) share price is $85.54, making it a Buy.
Verona Pharma Plc’s (VRNA) stock price is $85.54 and Verona Pharma Plc’s (VRNA) 50-day simple moving average is 67.44, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $85.54 and Verona Pharma Plc’s (VRNA) 100-day simple moving average is 64.25, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $85.54 and Verona Pharma Plc’s (VRNA) 200-day simple moving average is 49.77, creating a Buy signal.

Verona Pharma (VRNA) Technical Indicators

Jun 07, 2025, 07:50 AM
Name
Value
Implied Action
RSI (14)
73.90
Sell
STOCH (9,6)
91.21
Sell
STOCHRSI (14)
92.91
Sell
MACD (12,26)
4.72
Sell
ADX (14)
22.24
Neutral
Williams %R
-5.98
Sell
CCI (14)
145.62
Sell
ATR (14)
3.33
-
Ultimate Oscillator
67.37
Neutral
ROC
23.03
Buy
Verona Pharma Plc’s (VRNA) Relative Strength Index (RSI) is 73.90, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Trend Strength Indicator (ADX) is 22.24, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Commodity Channel Index (CCI) is 145.62, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Price Rate of Change (ROC) is 23.03, creating a Buy signal.

FAQ

Is VRNA a Buy, Hold, or Sell?
Based on VRNA’s technical indicators, VRNA is a Buy.
    What is VRNA’s RSI (14)?
    VRNA’s RSI (14) is 73.90, which suggests VRNA is a Sell.
      What is VRNA’s MACD?
      VRNA’s MACD is 4.72, which suggests VRNA is a Sell.
        What is VRNA’s 5-day moving average?
        VRNA’s 5-day moving average is 83.93, which suggests VRNA is a Buy.
          What is VRNA’s 20-day moving average?
          VRNA 20-day moving average is 74.43, which suggests VRNA is a Buy.
            What is VRNA’s 50-day moving average?
            VRNA’s 50-day moving average is 67.44, which suggests VRNA is a Buy.
              What is VRNA’s 200-day moving average?
              VRNA’s 200-day moving average is 49.77, which suggests VRNA is a Buy.
                What is VRNA’s Williams % R (14)?
                VRNA’s Williams % R (14) is -5.98, which suggests VRNA is a Sell.
                  What is VRNA’s CCI (14)?
                  VRNA’s CCI (14) is 145.62, which suggests VRNA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis